RecruitingNCT06325813

ADHD PreSMA Response Inhibition Therapy

Device studyAges 12–17United States

The study in practice

Understand this study

Listed age limits: 12 years to 17 years.

Listed locations: Cincinnati, United StatesSee all locations and recruitment
Activities: Device procedures described in the protocol · Sham comparator
Compensation: Payment and expense reimbursement have not been verified.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: September 3, 2024

Recruitment status: Recruiting
Enrollment listed in the registry: 40
Sponsor: Children's Hospital Medical Center, Cincinnati
Sponsor type: Hospital / academic medical center
Study type: Device
Intervention type: DEVICE
Study phase: Not clearly listed
Locations: United States
Age range: From 12 Years to 17 Years
Official registry ID: NCT06325813
Official title: Show the full official title
ADHD PreSMA Response Inhibition Therapy

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Recruiting

Cincinnati

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Children's Hospital Medical Center, Cincinnati, a hospital or academic medical center.

Who can participate?

Listed age limits: 12 years to 17 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.